Jazz Pharmaceuticals (J7Z.XETRA) Q2 2026 Earnings

5MayConfirmed
Q2 2026
3.96
4.44
4.93
5.41

Details

Expected EPS
3.96084583412
Actual EPS
5.4104925999999995
Surprise EPS
1.45
Surprise Percent
+36.6%

Description

Jazz Pharmaceuticals (J7Z.XETRA) has reported earnings of 5.4104925999999995 per share for Q2 2026.

0 Comments

Share your thoughts